The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved.
COVID-19 and psoriasis: Should we fear for patients treated with biologics?
Amerio, Paolo
;Giuliani, Federica;Gualdi, Giulio
2020-01-01
Abstract
The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved.| File | Dimensione | Formato | |
|---|---|---|---|
|
dth.13434.pdf
Solo gestori archivio
Descrizione: Review Article
Tipologia:
PDF editoriale
Dimensione
574.41 kB
Formato
Adobe PDF
|
574.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
